Table 4 Laboratory and radiographic findings at hospital admission in all patients and by gender
From: Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study
N | All patients (N = 431) | Gender | |||
|---|---|---|---|---|---|
Female (N = 119) | Male (N = 312) | p | |||
Hemoglobin, g/L | 417 | 134 [123–148] | 127 [117–136] | 139 [126–150] | < 0.001 |
White blood cells, 109/L | 417 | 6.25 [4.98–8.83] | 5.92 [4.77–7.82] | 6.44 [5.06–8.95] | 0.10 |
Neutrophils, 109/L | 376 | 4.74 [3.55–7.21] | 4.52 [3.55–6.50] | 4.87 [3.55–7.32] | 0.50 |
Neutrophils, % | 376 | 77.7 [70.5–84.7] | 76.6 [69.7–84.2] | 78.0 [71.3–84.8] | 0.54 |
Lymphocytes, 109/L | 263 | 0.89 [0.58–1.23] | 0.89 [0.62–1.13] | 0.90 [0.58–1.24] | 0.68 |
Lymphocytes, % | 263 | 14.0 [7.9–19.5] | 14.6 [8.7–19.9] | 13.9 [7.6–19.3] | 0.56 |
Monocytes, % | 263 | 6.1 [3.9–8.1] | 5.2 [3.2–7.9] | 6.2 [4.2–8.3] | 0.048 |
Eosinophils, % | 263 | 0.00 [0.00–0.30] | 0.00 [0.00–0.30] | 0.00 [0.00–0.30] | 0.65 |
Basophils, % | 263 | 0.20 [0.10–0.30] | 0.20 [0.10–0.30] | 0.20 [0.10–0.30] | 0.75 |
Platelets, 109/L | 407 | 179 [140–226] | 209 [158–252] | 171 [136–212] | < 0.001 |
≥ 150—no. (%) | 407 | 290 (71.3) | 94 (83.9) | 196 (66.4) | < 0.001 |
INR, ratio | 353 | 1.07 [1.02–1.16] | 1.05 [1.01–1.12] | 1.08 [1.02–1.16] | 0.037 |
aPTT, ratio | 338 | 1.15 [1.04–1.29] | 1.09 [0.99–1.27] | 1.17 [1.06–1.30] | 0.024 |
AST, U/L | 410 | 49.0 [35.0–74.0] | 40.0 [29.0–55.0] | 53.0 [38.0–84.0] | < 0.001 |
ALT, U/L | 412 | 37.0 [25.0–59.0] | 30.0 [20.0–45.0] | 40.0 [27.0–62.0] | < 0.001 |
Total bilirubin, mg/dL | 372 | 0.60 [0.50–0.90] | 0.60 [0.40–0.80] | 0.70 [0.50–0.90] | 0.020 |
Creatinine, mg/dL | 414 | 0.92 [0.77–1.23] | 0.74 [0.61–0.91] | 0.98 [0.84–1.35] | < 0.001 |
Urea, mg/dL | 354 | 45.0 [34.0–66.0] | 38.0 [28.0–55.0] | 48.0 [37.0–71.0] | < 0.001 |
LDH, U/L | 371 | 384 [300–516] | 368 [291–484] | 391 [308–529] | 0.13 |
D-dimer, ng/mL | 13 | 2337 [1587–6028] | 4182 [1864–11437] | 2067 [1463–3328] | 0.32 |
Fibrinogen, g/L | 94 | 0.61 [0.49–0.71] | 0.53 [0.48–0.66] | 0.63 [0.49–0.72] | 0.19 |
CRP, mg/L | 417 | 113 [56–16.2] | 102 [48–145] | 122 [58–165] | 0.051 |
≥ 127—no. (%) | 417 | 188 (45.1) | 40 (35.4) | 148 (48.7) | 0.015 |
PCT, ng/mL | 84 | 0.49 [0.12–1.90] | 0.12 [0.05–1.00] | 0.56 [0.21–2.35] | 0.019 |
Na, mEq/L | 414 | 138 [136–141] | 138 [136–140] | 138 [136–141] | 0.86 |
K, mEq/L | 412 | 3.9 [3.6–4.3] | 3.8 [3.5–4.2] | 4.0 [3.7–4.3] | 0.028 |
Cl, mEq/L | 289 | 102 [99–104] | 101 [98–103] | 102 [99–104] | 0.46 |
Abnormalities at chest X-ray—no. (%) | 413 | 355 (86.0) | 98 (87.5) | 257 (85.4) | 0.58 |
Unilateral | 413 | 77 (18.6) | 17 (15.2) | 60 (19.9) | 0.27 |
Bilateral | 413 | 278 (67.3) | 81 (72.3) | 197 (65.4) | 0.19 |